Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Computational identification of novel antiviral leads against SARS-CoV-2 Mpro through systematic virtual screening and molecular dynamics study

The study identifies LY2784544 and Pimobendan as potential antiviral agents for Mpro, given their stability, strong binding energy (BE) profiles, and existing clinical data, these compounds warrant additional experimental validation to determine their potential efficacy against SARS-CoV-2.

M. Alam, Lina I. Alnajjar, Tarun Kumar Upadhyay et al. · 0 citations
Review Open access Aug 2026

Natural Compounds Targeting Oncogenic Signaling Networks in Glioblastoma: Molecular Mechanisms, Translational Advances, and Clinical Perspectives

The use of molecular diagnostics, including biomarkers, genetic profiling, and advanced imaging, has significantly improved early identification and patient stratification, and the combination of natural compounds shows potential for creating safe, effective, and pathway‐specific treatments for GBM.

Mehrukh Zehravi, Md Abul Hassan, Md. Al Amin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.